You are here: Home → Faculty and Staff → Daniel S Metzinger, MD

Daniel S Metzinger, MD

Assistant Professor University of Louisville School of Medicine Division of Gynecologic Oncology

Photo of Dr. Daniel MetzingerCertifications:
• American Board of Obstetrics and Gynecology, 2004
• Subspecialty in Gynecology Oncology, 2007

Education:
MD, University of Louisville School of Medicine, Louisville, KY

Residencies:
University of Louisville Hospital, Residency in Obstetrics and Gynecology, July 1994 - June 1998

Fellowships:
Mayo Clinic, Rochester MN, Fellowship in Gynecologic Oncology, June 1998 - June 2001

Clinical Interests:
da Vinci Robotic Surgery

Professional Societies:
• Greater Louisville Medical Society
• Kentucky Medical Association
• Louisville Obstetrical and Gynecological Society
• Society of Gynecologic Oncologists
• American College of Obstetrics and Gynecology

Leadership:
• Medical Advisory Board, Ovarian Awareness of Kentucky (O.A.K.)
• Cervical Cancer Medical Advisory Committee, Kentucky Women's Cancer Screening Program

Honors:
• Outstanding Teaching Professor, University of Louisville School of Medicine, Department of Obstetrics, Gynecology & Women's Health, June 2008
• CREOG Faculty Excellence in Resident Teaching Award, June 2002.
• University of Louisville Health Sciences Center Research Forum Award, April 1998
• University of Louisville Health Sciences Center Research Forum Award, April 1997

Selected Publications:

  • Sighn NP, Yolcu ES, Taylor DD, Gercel-Taylor C, Metzinger DS, Dreisbach SK, Shirwan H. A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity. Cancer Res. 63(14):4067-4073, 2003.
  • Giuntoli RL 2nd, Metzinger DS, DiMarco CS, Cha SS, Sloan JA, Keeney GL, Gostout BS. Retrospective review of 208 patients with leiomyosarcoma of the uterus: Prognostic indicators, surgical management and adjuvant therapy. Gynecol Oncol. 89(3):460-469, 2003.
  • Dowdy SC, Metzinger DS, Gebhart JB, Srivatsa P, Haddock MG, Suman VJ, Podratz KC. Salvage whole-abdominal radiation therapy after second-look laparotomy or secondary debulking surgery in patients with ovarian cancer. Gynecol Oncol 96:389-394, 2005.
  • Metzinger DS, Taylor DD, Gercel-Taylor C. Induction of p53 and drug resistance following treatment with cisplatin or paclitaxel in ovarian cancer cell lines. Cancer Letters 236(2):302-308, 2006.
  • Helm CW, Toler CR, Martin III RS, Gordinier ME, Parker LP, Metzinger DS, Edwards RP. Cytoreduction and intraperitoneal heated chemotherapy (IPHC) for the treatment of endometrial carcinoma recurrent within the peritoneal cavity. Int J of Gynecol Cancer 17(1);204-9, 2007
  • Helm CW, Randall-Whitis L, Martin R, Metzinger DS, Gordinier ME, Parker LP, Edwards RP. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma. Gynecol Oncol 105(1):90-6, 2007
  • Pendergrass M, Gordinier ME, Parker LP, Metzinger DS, Helm CW. Retraction of an intraperitoneal chemotherapy port: A case report and literature review. Int J Gynecol Cancer 17 (5):1131-1133, 2007.
  • Giuntoli RL, Gostout BS, DiMarco CS, Metzinger DS, Keeney GL. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior. J Reprod Med 52(11):1001-1010, 2007.
  • Gercel-Taylor C, Parker LP, Metzinger DS, Helm CW, Taylor DD. Estrogen receptor-alpha expression and ovarian cancer prognosis. Gynecol Oncol 112:S128, 2009.
Document Actions